GlassScriptPhysician profile
Marc A Nathanson
NPI 1356307045
$2,151.45
in general payments reported to CMS, 2019-2025
11 companies · $214 in 2025
The $214 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $80.06 · 2021: $1,278 · 2022: $259 · 2023: $200 · 2024: $120 · 2025: $214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $534.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $534.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,200.00 | 2021 | |
| Bioventus LLC | $158.37 | 2020-2021 | |
| Linvatec Corporation | $158.16 | 2025 | Biobrace 23mm |
| Metric Medical Devices, INC. | $134.26 | 2022 | |
| Abbvie INC. | $124.37 | 2022 | |
| Biocomposites INC | $100.54 | 2023 | Stimulan |
| Kerecis Limited | $99.79 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Treace Medical Concepts, INC. | $87.34 | 2024-2025 | |
| Aroa Biosurgery Incorporated | $44.60 | 2024 | |
| Djo, LLC | $30.35 | 2025 | Cmf |
| Cashflow Solutions, LLC | $13.67 | 2024 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Nathanson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.